A Science and Technology Blog
Phase-2 trial using a single dose of recombinant adenovirus vaccine (Ad5-nCoV) vector carries the genetic material that codes for spike glycoprotein of novel coronavirus was found to be safe, well-tolerated,…
A realistic (but very optimistic) timeline from the start of Phase-1 to the completion of Phase-3 could be about six to nine months (if all goes exactly according to plan),…
A day after serious concerns were raised, ICMR has reversed its stand. It says its decision to fast-track the trial process was only to cut the red-tape and not to…
On July 2, ICMR had sent a threatening letter sent to principal investigators at 12 sites to complete the Phase-1/phase-2 trail of India’s first indigenous COVID-19 vaccine by August 15.…
With the pandemic raging across many countries and the demand for a safe, efficacious vaccine being huge, availability of an indigenous vaccine will mean guaranteed availability for Indians, while a…
The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are expected by the first week of July. Serum Institute of…
While a single dose induced antigen-specific antibody and T cells responses in pigs, the booster dose enhanced the antibody responses with a significant increase in neutralising antibody levels. There was…
Gilead plans to begin a Phase-1 clinical trial in August of an inhaled version of remdesivir for early-stage COVID-19 treatment outside of hospital settings. The drug is currently approved for…
